MW 489.5 Cardiogen (20mg) Peptide-High Purity Research Grade Vials

MW 489.5 Cardiogen (20mg) Peptide-High Purity Research Grade Vials

Products Description

Description of Cardiogen 20mg (Bioregulator)

Cardiogen is a bioregulatory peptide known for its potent effects on cardiac health and other systemic benefits, including potential anticancer properties, particularly against sarcomas. With primary research focusing on heart conditions such as heart attacks, hypertension, and chronic heart failure, Cardiogen also shows a synergistic effect with established therapies, enhancing treatment efficacy and reducing adverse effects.

Product Usage: Cardiogen is designated strictly for research use, intended for in vitro experimentation and laboratory studies only. All product information provided is for educational purposes, emphasizing that the bodily introduction of this compound into humans or animals is strictly prohibited by law. This peptide should only be handled by licensed, qualified professionals and is not to be classified or misused as a drug, food, or cosmetic.

Introduction of Cardiogen 20mg

Cardiogen, a short peptide bioregulator, has demonstrated significant potential in the treatment of cardiovascular diseases, offering a new approach to managing conditions traditionally treated with standard therapies. Besides its cardiovascular benefits, Cardiogen has shown promise in oncological applications and may play a role in treating prostate-related issues.

Detailed Overview and Research Insights
Cardiovascular Benefits
Cardiogen has a profound impact on the heart by modulating fibroblast activity, which is crucial for tissue repair and scar formation. Its ability to enhance cardiomyocyte proliferation while inhibiting excessive fibroblast proliferation leads to reduced scar formation and better outcomes in cardiac remodeling, ultimately preventing heart failure.

Anticancer Potential
Interestingly, while Cardiogen reduces apoptosis in cardiac cells by down-regulating p53 protein expression, it enhances apoptosis in cancer cells, specifically in sarcoma models. This dual action suggests that Cardiogen can selectively target tumor cells based on their unique vascular characteristics, potentially offering a new avenue for cancer treatment that could be synergistic with existing therapies.

Prostate Health
In the context of prostate health, Cardiogen affects fibroblast signaling factors, which are crucial in creating a microenvironment conducive to prostate cancer development and progression. Research indicates that Cardiogen can normalize these signaling factors, potentially offering benefits in both the prevention and management of prostate cancer.

Product Images 

FAQ

Q1: Can I get some samples?

A: Yes, we can provide samples. However, customers must bear the shipping cost.

Q2: How to pay?

A: We accept various payment methods, including T/T and other options.

Q 3: What is your MOQ (Minimum Order Quantity)?

A: Our standard MOQ is 5kits. However, smaller quantities, such as 100 grams, can be arranged for a corresponding sample fee.

Q 4: What is the shipping time?

A: Orders are usually shipped within 3-7 days with a tracking number. Delivery times vary by destination. Please get in touch with us for details.